Close Menu
Home » lymphoma

lymphoma

Dec 09, 2014

Immunosequencing Comes of Age as Researchers Demo Clinical Utility, Aim for FDA-cleared Products

Premium

Researchers are demonstrating that sequencing the immune repertoire can offer valuable insight into blood cancers, treatment response, and the likelihood of relapse.

Nov 20, 2014

Mirna Releases Phase I Data Showing Manageable Safety Profile for microRNA Rx

Premium

The data also indicate early signs of clinical activity in certain patients.

Nov 17, 2014

Sequenta, Illumina Strike IVD Deal for NGS-based Test to Monitor Residual Disease

Sequenta and Illumina have struck an agreement to commercialize an in vitro diagnostic kit based on Sequenta's minimal residual disease detection and quantification technology.

Sep 24, 2014

Denovo Taking on Failed Phase III Lilly Drug to Pursue for Genomic Responder Subset

Premium

NEW YORK (GenomeWeb) — Biomarker development firm Denovo Biopharma has acquired the late-stage oncology drug enzastaurin from Eli Lilly and Company, and plans to use its genotyping platform to uncover a genomic marker or markers that can support new clinical trials advancing the drug for a genomi

Sep 12, 2014

Advanced Cell Diagnostics Preps HPV Assay for Launch, Seeks Entry into Clinical Dx Market

NEW YORK (GenomeWeb) – After gaining traction in the research market, Advanced Cell Diagnostics is poised to bring its RNA detection technology to the clinical space.

Sep 03, 2014

Mirati Therapeutics Using NGS to Identify Best Responders to Multiple Oncology Drugs

Premium

NEW YORK (GenomeWeb) – Mirati Therapeutics is studying a number of personalized medicine cancer drugs, for which it is planning to use next-generation sequencing platforms to interrogate complex genetic markers associated with patient response.

Aug 25, 2014

Cancer Genetics, Keck Researcher Team on Lymphoma Markers

NEW YORK (GenomeWeb) – Cancer Genetics today said that it will collaborate with a researcher at Keck Medicine of the University of Southern California to identify genomic markers of diffuse large B-cell lymphoma.

Jun 04, 2014

NanoString to Develop Companion Dx for Celgene Lymphoma Drug Study

NEW YORK (GenomeWeb) – NanoString Technologies said after the close of the market Tuesday that it will develop a companion diagnostic test for Celgene's Revlimid (lenalidomide), which the firm is developing for diffuse large B-cell lymphoma.

May 08, 2014

Idera Taps Abbott to Develop CDx for B-Cell Lymphoma Drug Candidate

NEW YORK (GenomeWeb) — Idera Pharmaceuticals said today that it has entered into an agreement with Abbott to develop an in vitro companion diagnostic test for use in Idera's clinical development programs to treat certain genetically defined forms of B-cell lymphoma with its lead drug can

May 08, 2014

Dx Focus: BD Diagnostics; Idera and Abbott; Curetis; Epistem; DaVita Kidney Care and Roche

Premium

BD Diagnostics, a segment of Becton Dickinson, this week announced the availability of the US Food and Drug Administration-cleared BD MAX Enteric Bacterial Panel for use on the BD MAX system.

Pages

The Scan

If They Don't Know...

Bloomberg Law writes that the Genetic Information Nondiscrimination Act may work better as a privacy, rather than anti-discrimination, law.

New Startup from Avey

TechCrunch reports that Linda Avey has a new personal genomics startup that's focusing on India.

No Longer 'Uncontested'

A new report finds that though the US has increased its activity in science and engineering, its global share of that activity has fallen in some areas, according to Inside Higher Ed.

Nature Papers Include Analysis of Rapeseed Genome, Target Enrichment Method for Metagenomics

In Nature this week: genomic analysis of rapeseed, universal target enrichment method for metagenomic sequencing, and more.

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.